Skip Navigation


Epidemiologic Reviews Advance Access originally published online on May 26, 2006
Epidemiologic Reviews 2006 28(1):47-53; doi:10.1093/epirev/mxj002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/1/47    most recent
mxj002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Naleway, A. L.
Right arrow Articles by Mullooly, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naleway, A. L.
Right arrow Articles by Mullooly, J. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Epidemiologic Reviews Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.

ARTICLES

Delivering Influenza Vaccine to Pregnant Women

Allison L. Naleway1, Wendy J. Smith2 and John P. Mullooly1

1 Center for Health Research, Kaiser Permanente Northwest, Portland, OR
2 Department of Obstetrics and Gynecology, Kaiser Permanente Northwest, Portland, OR

Correspondence to Dr. Allison Naleway, Center for Health Research, Kaiser Permanente Northwest, 3800 North Interstate Avenue, Portland, OR 97227 (e-mail: allison.naleway{at}kpchr.org).

accepted for publication March 27, 2006.

Pregnant women have an increased risk of influenza infection and complications. The Advisory Committee on Immunization Practices currently recommends vaccination for women who are pregnant during influenza season. The authors review the literature concerning influenza vaccine safety, effectiveness, and coverage rates during pregnancy, as well as opportunities to improve vaccination rates during pregnancy. No study has demonstrated an increased risk of maternal complications or adverse fetal outcomes associated with inactivated influenza vaccine. Few studies have examined the effectiveness of vaccination during pregnancy, and the results from these studies are inconsistent, with some showing a protective effect and others showing no effect. Despite the proven safety of vaccination and the possible benefits to women and their infants, reported vaccination rates during pregnancy are generally less than 10%. Mothers frequently cite concerns about vaccine safety as a barrier to vaccination. Lack of adequate information about the risks and benefits of vaccination is reported by both patients and obstetric care providers. Organizational factors such as lack of vaccine storage facilities may also limit vaccination during pregnancy. Effective interventions should target factors pertaining to patients or providers, or they should address organizational or logistic barriers. The Advisory Committee on Immunization Practices currently recommends standing orders programs or reminders for patients and providers as strategies to improve vaccination rates.

influenza, human • pregnancy • vaccination


ACIP, Advisory Committee on Immunization Practices


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
S. Shah
Strategies for Vaccination of Close Contacts and Expectant Parents of Infants: The Next Immunization Frontier for Pediatricians
Arch Pediatr Adolesc Med, May 1, 2009; 163(5): 410 - 412.
[Full Text] [PDF]


Home page
NEJMHome page
K. Zaman, E. Roy, S. E. Arifeen, M. Rahman, R. Raqib, E. Wilson, S. B. Omer, N. S. Shahid, R. F. Breiman, and M. C. Steinhoff
Effectiveness of Maternal Influenza Immunization in Mothers and Infants
N. Engl. J. Med., October 9, 2008; 359(15): 1555 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. L. Naleway and J. P. Mullooly
TWO OF THE AUTHORS REPLY
Am. J. Epidemiol., February 1, 2007; 165(3): 352 - 353.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. M. Ayoub and F. E. Yazbak
RE: "DELIVERING INFLUENZA VACCINE TO PREGNANT WOMEN"
Am. J. Epidemiol., February 1, 2007; 165(3): 351 - 352.
[Full Text] [PDF]


Home page
Epidemiol RevHome page
M. A. Ibrahim
Editorial: Vaccines and Public Health
Epidemiol. Rev., August 1, 2006; 28(1): 1 - 2.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. R. Hinman, W. A. Orenstein, and L. E. Rodewald
Vaccines--Victories and Challenges
Am. J. Epidemiol., August 1, 2006; 164(3): 197 - 199.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.